NDC 0591-2136
Propofol
Propofol
Propofol is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Propofol.
| Product ID | 0591-2136_08798d87-7c60-429d-bf0b-fcc6f93fddaa |
| NDC | 0591-2136 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Propofol |
| Generic Name | Propofol |
| Dosage Form | Injection, Emulsion |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2016-01-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA205307 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | PROPOFOL |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0591-2136-51
20 VIAL in 1 CARTON (0591-2136-51) > 50 mL in 1 VIAL (0591-2136-55)
| Marketing Start Date | 2016-01-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0591-2136-51 [00591213651]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
NDC 0591-2136-57 [00591213657]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
NDC 0591-2136-68 [00591213668]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
NDC 0591-2136-95 [00591213695]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
NDC 0591-2136-55 [00591213655]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
NDC 0591-2136-80 [00591213680]
Propofol INJECTION, EMULSION
| Marketing Category | ANDA |
| Application Number | ANDA205307 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-07 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| PROPOFOL | 10 mg/mL |
OpenFDA Data
| SPL SET ID: | 6f8bebf9-d87b-469a-911a-21135ba841ae |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- General Anesthesia [PE]
- General Anesthetic [EPC]
- General Anesthesia [PE]
- General Anesthetic [EPC]
NDC Crossover Matching brand name "Propofol" or generic name "Propofol"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0209 | Propofol | Propofol |
| 0069-0234 | Propofol | Propofol |
| 0069-0248 | Propofol | Propofol |
| 0404-9943 | PROPOFOL | propofol |
| 0409-4699 | PROPOFOL | PROPOFOL |
| 0409-6010 | PROPOFOL | PROPOFOL |
| 0591-2136 | Propofol | Propofol |
| 0641-6194 | Propofol | Propofol |
| 0641-6195 | Propofol | Propofol |
| 0641-6196 | Propofol | Propofol |
| 16714-528 | propofol | propofol |
| 16714-690 | propofol | propofol |
| 16714-977 | propofol | propofol |
| 23155-345 | propofol | propofol |
| 25021-608 | propofol | propofol |
| 50090-4569 | Propofol | Propofol |
| 51662-1293 | PROPOFOL | PROPOFOL |
| 51662-1470 | PROPOFOL | PROPOFOL |
| 51662-1471 | PROPOFOL | PROPOFOL |
| 52584-054 | Propofol | Propofol |
| 52584-098 | PROPOFOL | propofol |
| 52584-699 | Propofol | Propofol |
| 18124-027 | Fresenius Propoven 2% | PROPOFOL |
Trademark Results [Propofol]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PROPOFOL 90235915 not registered Live/Pending |
Twilight Co. 2020-10-05 |
 PROPOFOL 87725806 5534295 Live/Registered |
Liu Xiaojiao 2017-12-19 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.